Form DEFR14A - Revised definitive proxy soliciting materials:
SEC Accession No. 0001104659-24-063385
Filing Date
2024-05-20
Accepted
2024-05-20 16:00:16
Documents
4

Document Format Files

Seq Description Document Type Size
1 DEFR14A tm2413608-4_defr14a.htm DEFR14A 719919
2 GRAPHIC lg_transcodetheraptm-4c.jpg GRAPHIC 10109
3 GRAPHIC px_2024transcode01pg1-bw.jpg GRAPHIC 293333
4 GRAPHIC px_2024transcode01pg2-bw.jpg GRAPHIC 229305
  Complete submission text file 0001104659-24-063385.txt   1423903
Mailing Address 6 LIBERTY SQUARE #2382 BOSTON MA 02109
Business Address 6 LIBERTY SQUARE #2382 BOSTON MA 02109 857-301-6857
Transcode Therapeutics, Inc. (Filer) CIK: 0001829635 (see all company filings)

EIN.: 811065054 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFR14A | Act: 34 | File No.: 001-40363 | Film No.: 24964259
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)